Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care

Elderly Clinical Trial

— OPTISORT  

Official title:

Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care, From Hospital to Home: Impact on Readmission at 30 Days After Delivery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03666793
• Other study ID #: RC-P0069
• Status: Completed
• Phase: N/A
• Start date: September 18, 2018
• Est. completion date: January 17, 2019

Study information

• Verified date: March 2019
• Source: Lille Catholic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days after hospital discharge. It compares a group of patients receiving comprehensive care (medication reconciliation at hospital entry, multidisciplinary medication review, and medication reconciliation at discharge), versus another group that does not benefit from the program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 109
• Est. completion date: January 17, 2019
• Est. primary completion date: December 17, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients hospitalized in the department of short geriatric stay

Exclusion Criteria:

• Patients already included in the study, and readmitted in the same service.

Related Conditions & MeSH terms

• Elderly
• Medication Reconciliation
• Patient Readmission

Intervention

Other:
• global care
Medication Reconciliation at admission, Multidisciplinary medication review, Medication Reconciliation at discharge

Locations

Country	Name	City	State
France	GHICL	Lomme

Sponsors (1)

Lead Sponsor	Collaborator
Lille Catholic University

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of readmission at 30 days	Evaluate the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days of return to home.Only direct re-admissions to emergency and geriatric short-stay services in participating centres will be counted.	30 days
Secondary	Time between discharge and first readmission	Evaluate the impact of medication management on the time required for the first re-admission to hospital, if it takes place before 30 days.	30 days
Secondary	Rate of changes in the prescription after hospital discharge by the general practitioner	Estimate the impact of this process on the preservation of the prescription after hospital discharge by general practitioner within the 30 days following the return home actual number of discrepancies, what may have caused the change and which are the concerned drugs	30 days
Secondary	Identification of Seniors at Risk (ISAR) score	This score is based on 6 yes/no questions. T e total scale range is from 0 to 6. Each item is scored 1 if there is a problem or 0 if there is not, being the maximum score =6.	30 days